When using a staged approach to eradicate chronic infection after total hip replacement, systemic delivery of antibiotics after the first stage is often employed for an extended period of typically six weeks together with the use of an in situ antibiotic-eluting polymethylmethacrylate interval spacer. We report our multi-surgeon experience of 43 consecutive patients (44 hips) who received systemic vancomycin for two weeks in combination with a vancomycin-and gentamicin-eluting spacer system in the course of a twostage revision procedure for deep infection with a median follow-up of 49 months (25 to 83).
When using a staged approach to eradicate chronic infection after total hip replacement, systemic delivery of antibiotics after the first stage is often employed for an extended period of typically six weeks together with the use of an in situ antibiotic-eluting polymethylmethacrylate interval spacer. We report our multi-surgeon experience of 43 consecutive patients (44 hips) who received systemic vancomycin for two weeks in combination with a vancomycin-and gentamicin-eluting spacer system in the course of a twostage revision procedure for deep infection with a median follow-up of 49 months (25 to 83).
The antibiotic-eluting articulating spacers fractured in six hips (13.9%) and dislocated in five patients (11.6%). Successful elimination of the infecting organisms occurred in 38 (92.7%) of 41 hips with three patients developing superinfection with a new organism.
We conclude that prolonged systemic antibiotic therapy may not be essential in the twostage treatment of a total hip replacement for Gram-positive infection, provided that a high concentration of antibiotics is delivered locally using an antibiotic-eluting system.
Infection is a catastrophic complication of total hip replacement (THR). It occurs following 1% or more of primary procedures. [1] [2] [3] Several methods have been described for the evaluation of chronic peri-prosthetic infection 4 with surgical techniques following a common objective of thorough debridement and removal of all foreign material. This approach is based on the ability of some micro-organisms to adhere to foreign material under a covering of glycocalyx and thereby to evade both the host immune response and antibiotic therapies. 5 Methods of antibiotic delivery to a debrided tissue bed include systemic therapy alone, the use of a locally eluting antibiotic polymethylmethacrylate (PMMA) carrier or a combination of both. The local delivery of antibiotics in combination with systemic therapy has been shown to be superior to systemic therapy alone in two-stage procedures. 6 This approach has been reported as the method of choice for peri-prosthetic infection with reports usually describing an extended period of systemic antibiotic treatment [6] [7] [8] [9] [10] [11] after the first-stage debridement, although the optimum length of antibiotic treatment has not been definitively established. 12 There have been few reports of the outcome after long periods of systemic antibiotic treatment. Some have reported a higher rate of infection with treatment for less than four weeks, 13 in the absence of a local antibiotic eluting system. Others have reported good results with treatment for less than six weeks 14, 15 and also poor results with no systemic treatment in combination with an antibiotic eluting system. [16] [17] [18] [19] Staged surgical approaches using antibiotic-impregnated PMMA in various forms have been reported including prefabricated beads, custom beads and articulating spacers, 9, [19] [20] [21] with the reported success of the last being comparable with that of other twostage procedures. 8, 20, 21 Articulating spacers maintain the length of soft tissues, minimise limb shortening, avoid periarticular scarring and muscle contracture, preserve bone quality and reduce the energy requirements for gait. 8, 21 We report our experience of treating patients with a proven infection of the hip by a two-stage revision technique using an antibiotic-eluting spacer and interim systemic treatment with vancomycin for two weeks.
Our objective was to demonstrate that successful eradication of Gram-positive infection can be achieved by a shortened period of systemic antibiotic treatment between stages, while delivering high local concentrations of antibiotics by means of an antibiotic-eluting spacer.
Patients and Methods
Between 1998 and 2003 we treated 43 consecutive patients (44 hips) with chronic peri-prosthetic infection of the hip using a two-stage revision procedure with a vancomycinand gentamicin-impregnated articulating acrylic cement spacer. The diagnosis of infection was confirmed by either positive microbiological or histological results. Data were collected prospectively and reviewed retrospectively. Patients in whom a diagnosis of infection could not be confirmed on microbiological or histological results were excluded from the study.
Criteria used to confirm infection at the first stage of surgical debridement include either a neutrophil infiltrate on histological analysis 22 in the absence of an inflammatory arthropathy or the presence of the same organism in two or more samples on microbiological culture. 23 Inflammatory markers were considered to be raised when the erythocyte sedimentation rate (ESR) was more than 30 mm/hr (normal range 0 to 15 mm/hr) or the C-reactive protein level (CRP) was greater than 10 mg/l (normal range 0 mg/l to 5 mg/l). 24 The patients had a mean age of 69 years (33 to 90). The Charnley categories 25 are shown in Table I . The primary diagnosis for THR included primary osteoarthritis in 28 patients, inflammatory arthropathy in eight and posttraumatic osteoarthritis in seven.
Most patients (33) were taking antibiotics at the time of their referral. Treatment with antibiotic suppression was undertaken only when the patient's comorbidity precluded surgery. Prior to revision antibiotics were withheld for a minimum of two weeks. Surgery was performed in a laminar air-flow environment with disposable drapes and impervious gowns. At the first-stage a transtrochanteric approach was used for radical debridement which was performed using revision instruments and a high-speed burr to allow removal of the infected components and avascular soft tissue and bone.
Before the administration of antibiotics and avoiding disturbance of bone cement when feasible, 26 five tissue specimens including capsular tissue and acetabular and femoral membrane were taken for histological analysis 22 and microbiological culture 23 using individual sterile instrument sets to avoid cross-contamination. Antibiotic treatment was by vancomycin and gentamicin articulating cement spacer (Fig. 1) and systemic vancomycin for two weeks. Serum levels were monitored and dose titration was performed to maintain a pre-dose serum concentration in excess of 5 mg/l. Vancomycin was chosen because of its effectiveness against Grampositive infection, including gentamicin-resistant staphylococci which can be selected out by the use of gentamicin in the bone cement for primary surgery.
The spacer was made using three 40 g batches of Palacos R cement 27 containing 0.25 g of gentamicin per batch (Schering-Plough Ltd, Welwyn Garden City, United Kingdom), with 2.0 g of vancomycin added per 40 g batch of cement, before addition of the liquid monomer. The cement was then injected into a silicone mould system (Biomet Merck UK Ltd, Bridgend, United Kingdom) to form an articulating spacer in the shape of a unipolar hemiarthroplasty. These single-use mould systems came in three sizes, with femoral head diameters of 51 mm, 57 mm and 64 mm. The smallest of these was the most frequently used because of the stem size. The press-fit cement spacer was allowed to cure sufficiently before it was inserted in order to decrease interdigitation into bone, thereby allowing removal with minimal difficulty and bone loss at the second stage. In the presence of deficient femoral bone when the proximal third of the spacer was unsupported or when there were bone defects near the tip of the spacer, the following modifications were made. A femoral nail was cut to the desired length and inserted into the stem portion of the spacer mould before the cement was polymerised with further cement used to coat the distal aspect of the nail. This modified system was used to enhance stability and to bypass stress risers in the femur. Patients were discharged when their wound was dry and when they were able to achieve protected weight-bearing.
At the start of the period, the process for microbiological culture involved direct plate inoculation and liquid enrichment for two days with a secondary plate subculture as outlined in the United Kingdom national standard methods for the investigation of tissues and biopsies. 28 Aerobic plates were only incubated for 48 hours. Microbiological culture methods were modified to avoid manipulation of the samples which could result in laboratory contamination. By the end of the study period the following methodology was in use to increase the number of isolates of clear significance. Pea-sized samples were collected in the clean-air theatre and placed into pre-prepared universal glass bottles containing 2 ml of special peptone (Oxoid, Basingstoke, United Kingdom) with 20 pre-washed ballotini glass beads for shaking and homogenisation in the laboratory. The peptone was immediately subcultured to blood agar incubated in 10% CO 2 and anaerobically with all culture plates incubated for seven days. Antibiotic susceptibility tests for gentamicin and methicillin were performed using the British Society for Antimicrobial Chemotherapy disc method 29 and the minimum inhibitory concentration for vancomycin and teicoplanin determined by the E-test. During the interval between the first-and second-stage procedures, patients received vancomycin for two weeks through a peripherally inserted central cannula and were reviewed by serial clinical examination and radiological and laboratory tests. The timing of the second-stage was guided by the recovery of the inflammatory markers towards normal levels at six weeks, with repeat debridement scheduled in three patients when this did not occur.
During the second-stage procedure a further debridement was performed with tissue samples sent for microbiological and histological analysis in a manner similar to that of the first-stage procedure. Revision procedures with cemented components used Palacos R cement (ScheringPlough Ltd) with 1 g of vancomycin added per 40 g batch, with appropriate antibiotic modification in the presence of Gram-negative infection at the first-stage surgery. Parenteral antibiotics were administered post-operatively until the intra-operative tissue culture and histological results were available. Post-operatively, the patients were assessed clinically and radiologically at six weeks, at three, six and 12 months and annually thereafter, with none being lost to follow-up. After the second stage the radiographs were evaluated for the presence of radiolucent zones 30, 31 around both the femoral 32, 33 and the acetabular 34 components. The success of the treatment was defined as the elimination of the infecting organisms found at the first stage from all subsequent samples from the joint or the surgical wound at follow-up at two years. An interval of two years has been suggested as the assessment interval for new forms of antibiotic treatment for deep prosthetic joint infection by a working party of the Infection Disease Society of America and the Food and Drug Administration. 35 Positive cultures with an organism indistinguishable on speciation and antibiotic susceptibility tests from the infecting organisms found at the first-stage operation was defined as persistent infection, with superinfection being defined as the isolation from a deep sample taken later in the patient's post-operative course of an organism not encountered in the first-stage samples.
Results
A total of 14 patients had a history of alteration in their immune status secondary to diabetes, malignancy, hypogammaglobulinaemia, use of steroids, psoriasis and rheumatoid disease, with three of these developing an infection following the second-stage reconstruction. A total of 16 had previously had multiple surgical procedures on the affected hip (Table I) and nine presented with a sinus. There were 17 who presented with more than one joint replacement, with two of these having multiple peri-prosthetic joint sepsis. The mean number of surgical procedures undergone before presentation was 1.6 (1 to 8) with a median duration of symptoms before diagnosis of 12 months (3 to 36). Three patients had a repeat first-stage debridement. Three patients received a modified articulated spacer with an incorporated femoral nail. Six of 44 articulated spacers fractured (13.6%) after a mean of 132 days (3 to 450). Dislocation occurred in five patients (11.6%) who had associated soft-tissue attenuation from chronic infection and trochanteric nonunion. The changes in the ESR and CRP levels between stages and the complications are shown in Table II . The complications were treated conservatively with the patient mobilising non-weight-bearing.
All 43 patients (44 hips) underwent a second-stage procedure after a median interval between stages of 21 weeks (8 weeks to 23 months). In 13 patients this was delayed for more than six months for reasons of medical comorbidity. Three patients died within two years of their second-stage procedure from unrelated causes. Two of these had no clinical or radiological evidence of recurrent infection, with the remaining patient having a superinfection on subsequent cultures. In the remaining 41 hips, the mean pre-operative Merle D'Aubigné and Postel score 36 was 7.2 (4 to 16), which improved to 11.4 (8 to 16) at a median follow-up of 49 months (25 to 83), with the pain component improving most consistently. From the surviving 41 patients (41 hips), successful elimination of the infecting organisms occurred in 38 hips (92.7%). Superinfections were seen in three of the 44 hips (6.8%), two with rheumatoid disease culturing Enterococcus and a mixed growth and the third a mixed growth of coagulase-negative staphylococcus and Enterobacter cloacae. The time intervals between stages were similar for patients with recurrent infection (mean 32.4 weeks) compared with those in whom treatment had been successful (mean 27.3 weeks).
Complications after the second-stage re-implantation included one case of pulmonary embolus and one of deep-vein thrombosis. A trochanteric osteotomy was performed for the second-stage surgical approach in all but one when a posterolateral approach was used. The prostheses used included 11 uncemented and 33 cemented femoral components with 13 uncemented and 31 cemented acetabular reconstructions (Table III) . There were no cases of dislocation. Patients remaining free from infection after the second-stage showed no radiological signs of loosening 32, 34 of either the femoral or the acetabular component at the latest follow-up.
The micro-organisms cultured from tissue samples taken at both procedures are shown in Table IV . No strains of Staphylococcus aureus were vancomycin-or gentamicinresistant, although gentamicin resistance was seen with other organisms (Tables IV and V) . Unfortunately, information was not available on whether gentamicin-impregnated cement had been used at primary surgery. Although no permanent toxic effects were seen in our patients receiving a two-week regimen of vancomycin, transient renal impairment did occur in two patients. Additional treatment with ciprofloxacin was required in one patient with a Gramnegative infection.
Discussion
The shortened period of treatment with vancomycin in our study minimises the exposure of patients to the potentially serious side-effects while maintaining a successful eradication rate similar to that reported with regimes of longer duration. [6] [7] [8] [9] [10] [11] 20 The potential side-effects include venoirritation, nephrotoxicity and ototoxicity in addition to generic side-effects of antibiotics such as the induction of Clostridium difficile diarrhoea, which is related to prolonged use. The use of vancomycin also necessitates central venous administration and repeated blood sampling to monitor serum levels and renal function, with adjustment of the dose to minimise the associated morbidity.
In practice, vancomycin is active against all Gram-positive organisms without acquired resistance and in particular against gentamicin-resistant staphylococcus which may be increased by the use of gentamicin in the bone cement for primary surgery. Most infections are caused by Gram-positive organisms 7, [37] [38] [39] [40] [41] [42] [43] [44] which are covered by the post-operative use of systemic vancomycin without the unnecessary selection for resistance and Clostridium difficile of broad-spectrum agents such as cephalosporins and fluoroquinolones. If a Gram-negative infection is suspected from pre-operative blood cultures, aspiration of the joint or previous surgery, additional agents should be considered for use both within the antibiotic-eluting spacer and systemically.
A potential disadvantage of our regime is the dose of gentamicin within the spacer in the uncommon and unexpected occurrence of Gram-negative infection, when appropriate doses of > 1 g per 40 g cement have been advised. We had one such patient in our series, who received subsequent appropriate oral treatment with successful eradication of the infection which was maintained at the latest follow-up of three years. It is unlikely that the presence of gentamicin in the spacer contributed greatly to the outcome in our study, given the frequency of gentamicin resistance (Table IV) , the wellrecorded emergence of small-colony forms of Staphylococcus on gentamicin monotherapy in joint infection and its inactivity against enterococcal isolates which make it an unsuitable choice alone. At the time of surgery the routine use of a spacer loaded with antibiotics which, based on the United Kingdom antibiotic susceptibility data, are active against most Gram-negative organisms (gentamicin) and most Gram-positive organisms (vancomycin) is suitably broad spectrum without the necessity of further tailoring of individualised antibiotic regimens based on the pre-operative cultures provided that the occurrence of vancomycinresistant enterococci is rare in the orthopaedic unit. The origin of peri-prosthetic infection is debatable and the joint space, the prosthetic-bone interface or potentially both may be implicated. Vancomycin reportedly elutes well from Palacos R cement delivering high concentrations [45] [46] [47] [48] [49] [50] of antibiotic locally into the joint space. Although articulating PMMA spacers have a lower surface area compared with that of beads for antibiotic elution, they have been shown to be safe and effective in studies comparing the two methods. 20 Our preference of combination therapy with both systemic and local delivery was used to address the potential for metastatic joint infection in patients with multiple joint replacements, which was seen in two of our 43 patients at presentation. With low-virulence organisms such as coagulase-negative staphylococcus in which metastatic infection is rare, systemic antibiotics may not be necessary. However, we consider that with Staph. aureus in which metastatic infection is well described, systemic therapy is certainly of relevance. A combined antibiotic approach is therefore justified until the results of cultures are available, particularly if the joint is removed during an acute episode of infection.
Despite the intended regime of protected weight-bearing during mobilisation, there were fractures of the articulating spacers, none of which required an exchange procedure. The durability of the spacers was variable, with early structural failure seen in patients with poor weight-bearing compliance and later failure in those with a prolonged interval between stages. The full benefit of maintaining the length of soft tissues after the first stage is compromised in this scenario, although the spacers remain effective for eliminating dead space and there remains the potential for further antibiotic elution. 26 To address this issue some authors have reported Studies on the use of temporary spacers inserted through anterolateral, direct lateral (transtrochanteric) and posterolateral approaches have described dislocation in both antibiotic-loaded prostheses of hemi-arthroplasty design 9, 11 and alternative functional spacer systems. 8, 10, 11, 46 This reflects the difficulty in achieving stability in these patients who may have poor general health in addition to compromised local tissues in response to chronic peri-prosthetic infection. In particular, local soft-tissue factors associated with dislocation of the first-stage prosthesis in our series included trochanteric nonunion. In order to address these complications, consideration is now given to reinforcement of the antibiotic-loaded spacers with incorporation of a manually contoured metal rod and addressing the offset if required, by manipulating the silicone mould system with the contained bone cement before complete polymerisation.
Our patients received systemic vancomycin for a total of two weeks after the first-stage debridement which is a shorter duration than conventionally described. [8] [9] [10] [11] Twostage techniques for revision of infected THR have been reported using a variety of methods to deliver local antibiotics at high concentrations 19, 21 with the rate of successful eradication of infection being quoted as around 90% which is in keeping with our findings. Successful antibiotic regimes of duration of less than six weeks for chronic infection [14] [15] [16] [17] [18] [19] emphasise the use of aggressive surgical debridement in combination with the local delivery of a high concentration of antibiotics from an antibiotic-eluting cement spacer. The prolonged release of high concentrations of local antibiotics from the spacer is paramount given that the remaining, apparently healthy bone, may represent a source for infection with Staph. aureus reported to incorporate within osteoblasts in vivo, 37 obtaining sanctuary from antibiotic regimes and remaining active after osteoblast senescence. 51 A variable highlighted as important, although independent of local antibiotic delivery in the staged surgical treatment of prosthetic hip infection, involves the time delay between the stages 12 with longer intervals associated with a greater chance of success. We were not able to associate failure of treatment with the number of previous operations, the chronicity of infection, the time interval between stages or the organisms involved. Patients with comorbid risk factors for infection 52 appeared to have a higher rate of infection, although the numbers were small.
In the United Kingdom, staphylococcal resistance to vancomycin is considered when the minimum inhibitory concentration is > 4 mg/l, 29 although recent literature recommends that resistance be considered at the lower level of > 2 mg/l. 53, 54 In our series only one patient had a minimum inhibitory concentration of > 2 mg/l. This patient had a successful eradication of the infecting organism although subsequently developed a superinfection (Table V) . The optimum serum level of vancomycin is a potential issue for debate during the treatment of prosthetic joint infection. Failures in the treatment of bacteraemia with vancomycin have been reported when the concentrations of antibiotic at which visible bacterial growth ceases (minimum inhibitory concentration) > 1 mg/l). 55, 56 It is possible that this new mechanism of resistance may represent a problem in infection with Staph. aureus in orthopaedics. Reports of staphylococcal infection from North America relate to the genetics of the bacterial strain and may not relate to United Kingdom practice in which strains are of different lineages. 57, 58 Randomised studies reporting staphylococcal bacteraemia in the intensive-care setting have shown no improvement in outcome when trough levels of 20 mg/l were obtained suggesting that there is not a simple relationship between dosage and outcome. 59, 60 Further studies have shown that trough levels of 20 mg/l are associated with nephrotoxicity even in the absence of other agents.
We conclude that the prolonged administration of systemic antibiotics may not be essential to achieve a high rate of success in the eradication of Gram-positive chronic periprosthetic hip infection, provided that a thorough surgical debridement is combined with a system delivering high concentrations of antibiotics locally. 
